People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ResQ Pharma, Inc. | — | Pharmaceuticals | Seed | $2.3M | $3.0M | 2022 |
Joel Tune at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Joel Tune on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Bowman | 1 | 8 |
| Paul Burton | 1 | 4 |
| Todd Beck | 1 | 2 |
| Paul Hertz | 1 | 1 |
| Israel Rubinstein | 1 | 1 |
| Francis Wisniewski | 1 | 1 |
| Guy Weinberg | 1 | 1 |
| Antoinette Gawin | 1 | 1 |
| August H. Schupp | 1 | 1 |
| Dominic O'Keefe | 1 | 1 |
| Steve Bylina | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.